State-of-the-Art Lecture: Long-term outcomes in living liver donors
For ILTS members only, please join now or renew your membership.
Sorry, you don't have access to this webinar!
For ILTS members only, please join now or renew your membership.
Objectives
- Describe early and late clinical consequences of living liver donation
- Describe the long-term psychological impact of living liver donation
- Understand the gaps in the long-term care of living liver donors
Agenda
- Introduction of the State-of-the-Art-Lecture (Hiroto Egawa and Nazia Selzner)
- Long-term clinical outcomes in living liver donors (Mohamed Rela)
- Long-term psychological outcomes in living liver donors (Susan Abbey)
- Q&A
- Closing Remarks
Mohamed Rela
Prof Mohamed Rela, is a liver transplant surgeon with over 25 years of experience in the field. He has been a consultant surgeon at the Kings liver unit since 1993. He has been working in India since 2009 and now runs the busiest liver transplantation program in South India, performing over 200 liver transplants each year. He has authored over 600 peer-reviewed publications and a number of book chapters including a chapter in the latest edition of Gray’s Anatomy. The annual Master Class in Liver Disease series started by him in 2011 is one of the most popular academic events in South Asia, regularly attended by over a 1000 delegates from most South Asian countries. He is currently the President of the International Liver Transplantation Society (ILTS)
Susan Abbey
Dr. Abbey is a Professor of Psychiatry at University of Toronto Temerty Faculty of Medicine in the Department of Psychiatry and the Psychiatrist-in-Chief at University Health Network. Dr. Abbey is a Clinical Investigator at Toronto General Hospital Research Institute. She is an integral member of the Centre for Living Organ Donation at UHN and has specific interest in living liver donor’s well being.
Hiroto Egawa
Dr. Egawa is a liver transplant surgeon who contributed to establishing surgical skills, postoperative management, and transplant immunology in living donor liver transplantation. Significantly, he is a pioneer of ABO-incompatible LDLT and continues innovative works in antibody-mediated rejection in liver transplantation.
Nazia Selzner
Dr. Selzner is a Transplant Hepatologist and Medical Director of the Living Donor Liver Transplantation at the Ajmera Transplant Center, University Health Network, and Associate Professor of Medicine at the University of Toronto. Dr. Selzner is a Scientist at the Institute for Medical Science (IMS) as well as at the Toronto General Research Institute (TGRI). Her clinical research is focused on access to liver transplantation with ongoing work on LDLT. She is recipient of numerous national and international awards and has published extensively in the area of living organ donation, transplantation and reperfusion injury.
